AXIS Capital
Underwrites specialty insurance and selected treaty reinsurance worldwide.
Something off on this page? Send us feedback.
Profile
Underwrites specialty insurance and targeted treaty reinsurance through AXIS Insurance and AXIS Re. A portfolio reset moved the group away from catastrophe and property reinsurance toward less volatile specialty lines.
Writing specialty insurance and treaty reinsurance worldwide, the group operates through AXIS Insurance and AXIS Re. Its origins in a Bermuda market-capacity shortage shaped a focused underwriting platform rather than a broad retail-insurance model.
London and Lloyd’s scale expanded through the Novae acquisition. After a portfolio reset, it exited catastrophe and property reinsurance, concentrating instead on specialty insurance and targeted reinsurance lines including accident and health, casualty, and credit and surety. The business depends on underwriting and pricing specialized risks across global markets and on the integration of its insurance and reinsurance platforms.
Company facts
Categories
Key statistics
Year to date −4.5% · Average volume (30d) 662.9K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 3, 2026 | UBS | Reiterate | Buy | $131 | $126 |
| Aug 3, 2026 | Mizuho Securities | Target | $142 | $130 | |
| Jul 29, 2026 | Capital One Financial | Target | $108 | ||
| Jul 15, 2026 | Atlantic Equities | Target | $122 | ||
| Jul 9, 2026 | Mizuho Securities | Target | $137 | $142 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026Q2 FY26 | $3.25 | $2.84 | −12.6% | $1.74B | $1.75B | +0.6% | +1.90% |
| Apr 29, 2026Q1 FY26 | $3.33 | $3.42 | +2.7% | $1.72B | $1.64B | −4.7% | +2.50% |
| Jan 28, 2026Q4 FY25 | $2.97 | $3.25 | +9.4% | $1.63B | $1.73B | +6.4% | +0.26% |
| Oct 29, 2025Q3 FY25 | $2.72 | $3.25 | +19.5% | $1.45B | $1.60B | +10.6% | +5.95% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.47B | $1.54B | $1.69B | $1.73B | $1.64B | $1.75B | |
| Gross profit | $417.3M | $462.7M | $566.2M | $875.0M | $776.3M | $819.8M | |
| Operating income | $236.1M | $280.3M | $370.0M | $335.6M | $308.1M | $335.4M | |
| Net income | $194.1M | $223.4M | $301.9M | $289.6M | $254.8M | $383.3M | |
| Diluted EPS | $2.26 | $2.72 | $3.74 | $3.67 | $3.29 | $5.06 | |
| Gross margin | 28.4% | 30.0% | 33.4% | 50.4% | 47.2% | 46.8% | |
| Operating margin | 16.1% | 18.2% | 21.9% | 19.3% | 18.7% | 19.1% |
Fiscal years (4-quarter sums)FY21 $5.32B · FY22 $5.30B · FY23 $5.59B · FY24 $6.02B · FY25 $6.44B
Revenue by product · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $6.09B · Total debt $1.49B · Total assets $36.62B · Shareholders' equity $6.50B
Dividends
Raised for 21 straight years — most recently to $0.44 from $0.43 in Dec 2022. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 30, 2026 | Jun 30 | Jul 15 | $0.44 | |
| Mar 31, 2026 | Mar 31 | Apr 15 | $0.44 | |
| Dec 31, 2025 | Dec 31 | Jan 15 | $0.44 | |
| Sep 30, 2025 | Sep 30 | Oct 17 | $0.44 | |
| Jun 30, 2025 | Jun 30 | Jul 17 | $0.44 | |
| Mar 31, 2025 | Mar 31 | Apr 17 | $0.44 | |
| Dec 31, 2024 | Dec 31 | Jan 15 | $0.44 | |
| Sep 30, 2024 | Sep 30 | Oct 18 | $0.44 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 72.97M · Float 67.40M · 92.4% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| AQR Capital Management LLC | 4.23M | 5.80% | 13F | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 3.83M | 5.20% | 13G | Jul 14, 2026 |
| Vanguard Portfolio Management LLC | 3.79M | 5.19% | 13F | Aug 13, 2026 |
| BlackRock, Inc. | 3.44M | 4.71% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 3.20M | 4.38% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 7, 2026 | Henry B. Smith | director | −2,542 | $98.69 |
| Nov 19, 2025 | Charles A. Davis | director | −2,404,133 | $98.90 |
Peers
- Arch Capital Group
Global specialty insurer and reinsurer across commercial lines
- Everest Group
Worldwide P&C insurance and specialty reinsurance platform
- RenaissanceRe
Casualty and specialty (re)insurance for global counterparties
- Markel Group
Global specialty insurance for complex commercial risks
- Hamilton Insurance Group
Global specialty insurance and reinsurance across Bermuda and London
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| AXIS Capital | $99.52 | 0.00% | $7.26B | 6.3 | 7.6 | 1.1 | +7.4% |
| Arch Capital Group | $97.15 | −1.71% | $34.53B | 7.7 | 10.5 | 1.8 | −22.3% |
| Everest Group | $377.61 | −0.02% | $14.94B | 8.0 | 6.9 | 0.9 | −10.1% |
| RenaissanceRe | $330.74 | +0.01% | $13.74B | 5.7 | 8.3 | 1.3 | −28.5% |
| Markel Group | $1,818.69 | −0.07% | $22.53B | 10.0 | 15.8 | 1.3 | +17.6% |
| Hamilton Insurance Group | $35.35 | 0.00% | $3.53B | 6.1 | 8.0 | 1.2 | +12.2% |
| Median | 7.7 | 8.3 | 1.3 | −10.1% |